Clinical Trial Update: Cerebral Amyloid Imaging Using Florbetapir (AV-45) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on cerebral amyloid imaging with Florbetapir (AV-45) for dementia-related conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognition Disorders
• Dementia

Drugs mentioned

• Florbetapir (Florbetapir)

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Dementia, Cognition Disorders | Phase 3 | Status: UNKNOWN